Biogen Idec, Cardiokine terminate lixivaptan collaboration
Biogen Idec said that the step is consistent with its strategic decision to narrow its research and development (R&D) focus and terminate its efforts in cardiovascular medicine that
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
The agreement combines Sony DADC’s Blu-ray Disc manufacturing technology and manufacturing capacity with Caliper’s microfluidics expertise and patent portfolio to develop enabling solutions for life science researchers and